Nordic PharmaTech Consultancy ApS
CVR 45516598 · Private limited company (ApS) · Active · High risk
Nordic PharmaTech Consultancy ApS is a Private limited company (ApS), founded on , based in Værløse. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 4.5% over the next 12 months, which is 3.2 times the average for Danish companies. 1 annual report has been published. The latest annual report (31 Dec 2025) shows equity of DKK 40k and a net result of DKK -45k. CEO: Saad Moimini.
Bankruptcy risk for Nordic PharmaTech Consultancy ApS
3.2 × the average (1.41%) · higher risk than 91% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 45516598
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (1 years)
- Address
- Mosegård Park 1
3500 Værløse - Municipality
- Furesø
- Industry
- Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 20k
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 1 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 100.0% |
| Current ratio | – |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 1 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 |
|---|---|
| Revenue | DKK 0 |
| Gross profit | DKK -45k |
| Net profit | DKK -45k |
| Equity | DKK 40k |
| Total assets | DKK 40k |
| Cash | DKK 40k |
| Short-term debt | DKK 0 |
| Tax owed | DKK 0 |
Latest annual report: Reporting class B, mikrovirksomhed · auditor's statement: No assurance.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 27 Mar 2025 – 31 Dec 2025 | 129 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Saad Moimini | Current | |
| Owner (50%) | Moimini ApS | Current | |
| Owner (50%) | Ghobad Shahbazi Holding ApS | Current | |
| Founder | Moimini ApS | Current | |
| Founder | Ghobad Shahbazi Holding ApS | Current |
The CEOs' other companies
Saad Moimini – 1 other companies
- Moimini ApS Active
Address history (0 moves)
| Mosegård Park 1, 3500 Værløse |
Other companies at the same address
- Moimini ApS Active
Similar companies in Furesø
- Ydun ApS Farum
- SYNAPTIC ApS Værløse
- MULTIMERICS ApS Farum
- Amorphora IVS Farum
Questions and answers about Nordic PharmaTech Consultancy ApS
Has Nordic PharmaTech Consultancy ApS gone bankrupt?
No, Nordic PharmaTech Consultancy ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Nordic PharmaTech Consultancy ApS?
Our model estimates a bankruptcy risk of 4.5% over the next 12 months (high risk), which is 3.2 times the average for Danish companies.
Who is the CEO of Nordic PharmaTech Consultancy ApS?
Saad Moimini is the CEO of Nordic PharmaTech Consultancy ApS.
When was Nordic PharmaTech Consultancy ApS founded?
Nordic PharmaTech Consultancy ApS was founded on 27 March 2025.
What is the equity of Nordic PharmaTech Consultancy ApS?
Equity was DKK 40k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.